12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015)

Size: px
Start display at page:

Download "12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015)"

Transcription

1 12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015) Symposium Co-Chairs: Steven Cohen, Northeastern University Christopher Yu, Genentech, a Member of the Roche Group September 23-25, 2015 New York Marriott at Brooklyn Bridge Brooklyn, NY USA Organized by 1

2 Table of Contents Student Travel Grants... Program, Exhibitor and Media Partners... Scientific Final Program Summary... Plenary and Session Abstracts... Workshop... Technical Seminar Abstracts... Poster Abstracts... 2

3 Welcome to the 12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry We are pleased to welcome you to the 12th Symposium on the Practical Application of Mass Spectrometry in the Biotechnology Industry. The focus of this Symposium is the application of mass spectrometry for product characterization, process monitoring, formulation development and release testing in the pharmaceutical industry. Since mass spectrometry is a critical technology for a wide array of applications, the meeting will provide scientists in the industry an opportunity to share their data and learn from their colleagues. The symposium will feature a diversified selection of speakers from academia, industry and regulatory agencies, who will discuss applications of state-of-the-art mass spectrometry to proteins, glycans, nucleic acids, viral vectors and other molecules of therapeutic interest. The success of this symposium will depend not only on our experienced and knowledgeable speakers and workshop leaders, but also on the interactions and open discussion that take place among the attendees. We encourage you to participate wholeheartedly in the discussion sections that have been designed to stimulate exchange of ideas and information. We would like to thank the speakers who are giving generously of their time and resources, and you for your attendance, which will make this a successful endeavor. We gratefully acknowledge the generosity of our sponsors and exhibitors. Thank you to AbbVie, Inc., Agilent Technologies, Analytical Scientist, Biogen, Bio Tech International, BioProcess International, Bruker Daltonics, Inc., CMP Scientific, Eurofins Lancaster Laboratories, Inc., Genetic Engineering & Biotechnology News, Genedata AG, Genovis AB, IPQ, LCGC North America, Medicine Maker, New England Biolabs Inc., Pathologist, Pfizer, Inc., Protein Metrics, ProZyme, Inc., Roche Diagnostics GmbH & Genentech, a Member of the Roche Group, RSC Advances, separationsnow.com, SCIEX, Technology Networks Limited, Thermo Scientific and Waters Corporation. We are also thankful for the expert assistance and support of Renee Olson and CASSS, as well as the audiovisual expertise of Michael Johnstone from MJ Audio-Visual Productions. We hope you enjoy the conference, build new contacts and return for new information in 2015! THE ORGANIZING COMMITTEE: Greg Adams, FUJIFILM Diosynth Biotechnologies Alain Balland, Boehringer Ingelheim Pharma GmbH & Co. KG Michael Boyne, BioTechLogic, Inc. Patrick Bulau, Roche Diagnostics GmbH James Carroll, Pfizer, Inc. Steven Cohen, Northeastern University, (Co-chair) Eef Dirksen, Synthon Biopharmaceuticals B.V. Vivian Lindo, MedImmune, A member of the AstraZeneca Group Anders Lund, Genzyme, a Sanofi company Yelena Lyubarskaya, Biogen Jun Park, CDER, FDA David Passmore, Bristol-Myers Squibb Jason Rouse, Pfizer, Inc. Hansjörg Toll, Sandoz GmbH Christopher Yu, Genetech, a Member of the Roche Group (Co-chair) 3

4 CASSS Mass Spec Student Travel Grants CASSS is pleased to provide a limited number of student travel grants for PhD students and postdocs who present applicable posters at the 12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015). PhD students or postdoctoral fellows conducting research at academic institutions throughout the world are eligible. This symposium offers insight to current topics and issues under discussion within the biotech and biopharmaceutical industries, and as such, provides an opportunity to bridge between industry, academia and regulatory agencies. The presentations and workshops are focused on the application of mass spectrometry to advance drug discovery and development in the biotechnology industry. Applications will highlight uses of MS in various areas of product development including lead selection & optimization, high throughput screening, identification of PTMs, process development and in-process testing, drug product characterization, higherorder structure, and adoption of innovative MS technologies. Participants will have an excellent opportunity to meet, network and participate in exchanging knowledge for mutual education with other MS practitioners. Requirements are: -Present a poster on a MS topic -Proof of studentship/post-doc status -Recommendation from the supervisor/advisor This year s grant winners include: P-166_T Protein-Protein Interactions: Protein Footprinting and Mass Spectrometry Map the Interface of Marburg virus VP24 interacting with Keap1 Jing Li, University of Washington in St. Louis, USA Thursday, September 24 Young Scientist Session High Resolution Accurate Mass LC-MS/MS based Characterization of Industrial Cell Culture Media to Identify Compound Signatures of Process Variability Brian Morrissey, NIBRT - The National Institute for Bioprocessing Research and Training, Ireland P-167-F Intact Monoclonal Antibody Analysis via Microchip CE-MS Erin A. Redman, University of North Carolina, Chapel Hill, USA P-168-T Comprehensive Characterization of Human Growth Hormone Degradants by Integration of a Top-down and Bottom Mass Spectrometry Approach Annie Yu Wang, The Barnett Institute, Northeastern University, USA 4

5 The Organizing Committee gratefully acknowledges the following program partners for their generous support of this Symposium: Sustaining Program Partners Platinum Program Partners AbbVie, inc. Biogen Silver Program Partner Pfizer, Inc. Diamond Program Partner Agilent Technologies Platinum Program Partner Bruker Daltonics Genedata AG Gold Program Partners Roche Diagnostics GmbH & Genentech, a Member of the Roche Group SCIEX 5

6 Welcome Reception Bruker Daltonics Exhibitor Partners Agilent Technologies Bruker Daltonics, Inc. CMP Scientific Eurofins Lancaster Laboratories, Inc. Genedata AG Genovis AB New England BioLabs Inc. Protein Metrics ProZyme, Inc. SCIEX Thermo Scientific Waters Corporation 6

7 Media Program Partners Analytical Scientist Bio Tech International BioProcess International Genetic Engineering & Biotechnology News IPQ LCGC North America Medicine Maker Pathologist RSC Advances separationsnow.com Technology Networks Limited Supporting Organizations Chicago Mass Spectrometry Discussion Group Connecticut Mass Spectrometry Discussion Group Dutch Society for Mass Spectrometry German Society for Mass Spectrometry Greater Boston Mass Spectrometry Discussion Group MASSEP.org, A Separation Science Discussion Group Midwest Mass Spectrometry Discussion Group Pharmaceutical & Bioscience Society (PBSS) International Scripps Center for Metabolomics and Mass Spectrometry (SANDMAN) Washington-Baltimore Mass Spectrometry Discussion Group 7

8 Mass Spec 2015 Scientific Program Summary Tuesday, September 22, :30 08:30 Breakfast (Full Day and Morning Short Course Attendees ONLY) 08:00 13:30 Short Course Registration ONLY in the Louis M. Martini and Trefethen Foyer Short Course in the Park Slope Room Session Chair: Anders Lund, Genzyme, a Sanofi company, Framingham, MA USA 08:30 12:00 Fundamentals of Mass Spectrometry in the Analysis of Protein Therapeutics Anders Lund, Genzyme, a Sanofi company, Framingham, MA USA 12:00 13:00 Lunch (Full Day Short Course Attendees ONLY) 13:00 17:00 Applications of Mass Spectrometry to Characterize Protein Therapeutics Anders Lund, Genzyme, a Sanofi company, Framingham, MA USA 8

9 Wednesday, September 23, :00 18:00 Registration in the Ballroom Foyer 07:30 08:30 Breakfast in the Ballroom A-C 13:00 13:15 Welcome and Introductory Comments in the Ballroom D Steve Cohen, Northeastern University, Boston, MA USA Plenary I Session in Ballroom D Session Chair: Jason Rouse, Pfizer, Inc. Andover, MA, USA 13:15 14:15 Ultrahigh Resolution Mass Spectrometry: Extending the Size and Detail of Biomolecule Structure Analysis Alan Marshall, Florida State University, Tallahassee, FL USA 14:15 14:45 Break Visit the Exhibits and Posters in Ballroom A-C Process and Product Characterization Session in Ballroom D Session Chairs: Alain Balland, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany and Christopher Yu, Genentech, A Member of the Roche Group 14:45 15:15 Minimizing Trisulfides in Monoclonal Antibodies: Early Screening and Detection using Ultrahigh-Resolution Mass Spectrometry to Ensure Product Quality and Consistency Lisa Marzilli, Pfizer, Inc., Andover, MA USA 15:15 15:45 Application of Mass Spectrometry for Process Understanding and Advanced Process Control Kazumi Kobayashi, Biogen, Cambridge, MA USA 15:45 16:15 Implementing a LC/MS Based Multi-Attribute Method in GMP Environment Da Ren, Amgen Inc., Thousand Oaks, CA USA 16:15 16:30 The Application of High Resolution Top Down Mass Spectrometry to the Study of Degradation Reactions in Stability Samples of Protein Pharmaceutical Jeffrey Agar, Northeastern University, Boston, MA USA 9

10 Wednesday, September 23, 2015 continued 16:30 17:30 Technical Seminar Breakthrough Applications to Expand and Speed Biopharmaceutical Characterization Bryan Fonslow, SCIEX, Brea, CA USA Sponsored by SCIEX Ballroom D 17:30 19:00 Welcome Reception Hosted by Bruker Daltonics Location TBD 10

11 Thursday, September 24, :30 17:30 Registration in the Ballroom Foyer 07:30 08:30 Breakfast in Ballroom A-C 07:30 08:30 Technical Seminar Sponsored by Protein Metrics Ballroom D Plenary II Session in Ballroom A-C Session Chair: Steven Cohen, Northeastern University, Boston, MA USA 08:30 09:30 Innovative Instrumentation and Methods for Sequence Analysis of Antibodies and Posttranslationally-modified, Intact Proteins on a Chromatographic Time-scale Donald Hunt, University of Virginia, Charlottesville, VA USA 09:30 10:00 Break Visit the Exhibits and Posters in Ballroom A-C 10:00 11:00 Workshop I in Ballroom A-C Workshop Chair: Jason Rouse, Pfizer, Inc., Andover, MA USA Host Cell Proteins and Other Process Related Impurities Session in Ballroom D Session Chair: Patrick Bulau, Roche Diagnostics GmbH, Penzberg, Germany and Steven Cohen, Northeastern University, Boston, MA USA 11:00 11:30 Novel Approaches to Targeted Protein Analysis using LC-MRM in an HSV2 Vaccine Candidate Andrew James, Sanofi Pasteur Ltd., Toronto, ON Canada 11:30 12:00 An Accelerated LC-MS/MS Workflow for Assessment of the Host Cell Protein Composition during Biotherapeutic Process Development Don Walker, Genentech, A Member of the Roche Group, South San Francisco, CA USA 12:00 12:15 Break Please Take Lunch and Return to Ballroom D for Lunch and Learn 12:15 13:15 Technical Seminar: Lunch and Learn Sponsored by Agilent Technologies Ballroom D 11

12 Thursday, September 24, 2015 continued 13:15 13:30 Break - Visit the Exhibits and Posters in Ballroom A-C Young Scientist Session in Ballroom D Session Chair: James Carroll, Pfizer, Inc. St. Louis, MO USA 13:30 13:45 Impact of Sequence Variants on the HOS Analysis of Monoclonal Antibodies using an Optimized HDX-MS Method with Two Protease Column Approach Sasidhar Nirudodhi, Pfizer, Inc., Chesterfield, MO USA 13:45 14:00 High Resolution Accurate Mass LC-MS/MS Based Characterization of Industrial Cell Culture Media to Identify Compound Signatures of Process Variability Brian Morrissey, NIBRT, Dublin, Ireland 14:00 14:15 LC-MS Based Determination of Critical Attributes of a Novel Antibody-Drug Conjugate (ADC) Srikanth Kotapati, Bristol-Myers Squibb, Redwood City, CA USA 14:15 15:45 Poster Session I - Visit the Exhibits and Posters in Ballroom A-C Mass Spec Approaches for Quantitative Studies Session in Ballroom D Session Chair: Eef Dirksen, Synthon Biopharmaceuticals B.V., Nijmegen, The Netherlands and Vivian Lindo, MedImmune, A member of the AstraZeneca Group, Cambridge, United Kingdom 15:45 16:15 Data Analysis Strategies for Detecting and Characterizing Unknown Chemical and Posttranslational Modifications on Proteins John Valliere-Douglas, Seattle Genetics, Bothell, WA USA 16:15 16:45 Functional Assessment of Antibody Oxidation by Native Mass Spectrometry Markus Haberger, Roche Diagnostics GmbH, Penzberg, Germany 16:45 17:15 Understanding of Critical Quality Attributes of Biopharmaceuticals In Vivo Yinyin Li, Biogen, Cambridge, MA USA 17:15 18:15 Exhibitor Reception - Visit the Exhibits and Posters in Ballroom A-C 12

13 Friday, September 25, :30 17:00 Registration in the Ballroom Foyer 07:30 08:30 Breakfast in Ballroom A-C 07:30 08:30 Technical Seminar Routine and Advanced Comparability Studies for the Next Generation of Innovators and Biosimilars Asish Chakraborty, Waters Corporation, Milford, MA USA Sponsored by Waters Corporation Ballroom D Plenary III Session in Ballroom D Session Chair: Yelena Lyubarskaya, Biogen, Cambridge, MA USA 08:30 09:30 Rapid Production of Versatile Nanobody Repertoires Brian Chait, Rockefeller University, New York, NY USA 09:30 10:00 Break Visit the Exhibits and Posters in Ballroom A-C Regulatory Session in Ballroom D Session Chair: Michael Boyne, BioTechLogic, Inc., Glenview, IL USA 10:00 10:30 Characterization of Filgrastim using Intact and Top-down MS Johann Holzmann, Sandoz GmbH, Kundl, Austria 10:30 11:00 Applications of MS in Biosimilar Product Development and Similarity Assessment Jennifer Liu, Amgen Inc., Thousand Oaks, CA USA 11:00 11:30 The Use of Mass Spectrometry in FDA Applications for Biotherapeutics: A Retrospective Review Sarah Rogstad, CDER, FDA, Silver Spring, MD USA 11:30 12:30 Panel Discussion 12:30 12:45 Break Please Take Lunch and Return to Ballroom D for Lunch and Learn 13

14 Friday, September 25, 2015 continued 12:45 13:45 Technical Seminar: Lunch and Learn Unbiased in Depth Characterization of CEX-fractions from a Stressed Mab by MS Matthias Berg, Novartis Pharma, Basel, Switzerland Sponsored by Genedata AG Ballroom D 13:45 15:00 Poster Session II - Visit the Exhibits and Posters in Ballroom A-C Novel Technologies Session in the Ballroom D Session Chair: David Passmore, Bristol-Myers Squibb Company, Redwood City, CA USA 15:00 15:30 Mass Spectrometry Assisted Development of an Efficient In-silico Prediction Tool for Aspartate Degradation Sites Hans Rainer Voelger, Roche Diagnostics GmbH, Penzberg, Germany 15:30 16:00 Utility of Ion-Mobility Mass Spectrometry in Antibody Drug Conjugates Characterization Richard Huang, Bristol-Myers Squibb, Princeton, NJ USA 16:00 16:30 In-depth, Quantitative (Host Cell) Protein Fingerprinting of Adenovirus Based Vaccines by Mass Spectrometry Annemiek Verwilligen, Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands 16:30 16:45 Poster Award Announcement in Ballroom D 16:45 16:55 Closing Comments in Ballroom D Christopher Yu, Genentech, a Member of the Roche Group, South San Francisco, CA USA 14

14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017)

14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017) 14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017) Symposium Co-Chairs: Michael Boyne, BioTechLogic, Inc. Eef Dirksen, Synthon Biopharmaceuticals

More information

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016)

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016) Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016) Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto

More information

12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015)

12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015) 12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015) Symposium Co-Chairs: Steven Cohen, Northeastern University Christopher Yu, Genentech, a

More information

7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018)

7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018) 7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018) Symposium Co-Chairs: Guodong Chen, Bristol-Myers Squibb Company David Keire, CDER, FDA April 9-11, 2018 Omni Providence

More information

Welcome to. April 4-5, DoubleTree by Hilton Hotel Silver Spring, MD USA

Welcome to. April 4-5, DoubleTree by Hilton Hotel Silver Spring, MD USA Welcome to April 4-5, 2016 DoubleTree by Hilton Hotel Silver Spring, MD USA What is CASSS? Practical Applications of Mass Spectrometry EUROPE JAPAN NORTH AMERICA SOUTH AMERICA CASSS is the leading non-profit

More information

8 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2019)

8 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2019) 8 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2019) Symposium Co-Chairs: Katherine Bowers, FUJIFILM Diosynth Biotechnologies Guodong Chen, Bristol-Myers Squibb Company

More information

Welcome to. January 26, The Mayflower Hotel Washington, DC USA

Welcome to. January 26, The Mayflower Hotel Washington, DC USA Welcome to January 26, 2015 The Mayflower Hotel Washington, DC USA Mission Statement Provide a venue for biotechnology/biological product discussion that focuses on relevant CMC issues throughout the lifecycle

More information

Welcome to the CMC Strategy Forum

Welcome to the CMC Strategy Forum Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The

More information

4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015)

4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015) 4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015) Symposium Co-chairs: Jamie Moore, Genentech, a Member of the Roche Group Linda Narhi, Amgen Inc. April 13-15, 2015

More information

PRELIMINARY PROGRAM Bay Area Discussion Group

PRELIMINARY PROGRAM Bay Area Discussion Group PRELIMINARY PROGRAM Bay Area Discussion Group Co-chairs: Min Chen, Ultragenyx Pharmaceutical Vinaya Kapoor, Janssen, Pharmaceutical Companies of Johnson & Johnson South San Francisco Conference Center

More information

7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018)

7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018) 7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018) Symposium Co-Chairs: Guodong Chen, Bristol-Myers Squibb Company David Keire, CDER, FDA April 9-11, 2018 Omni Providence

More information

Welcome to the CMC Strategy Forum Europe 2016

Welcome to the CMC Strategy Forum Europe 2016 Welcome to the CMC Strategy Forum Europe 2016 The 10 th annual CMC Strategy Forum Europe, organized by CASSS, will explore a number of critical topics focused on improving the quality in development and

More information

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2018)

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2018) Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2018) Symposium Co-chairs: Christof Finkler, F. Hoffmann - La

More information

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. David Michels, Genentech, a Member of the Roche Group

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. David Michels, Genentech, a Member of the Roche Group CE in the Biotechnology & Pharmaceutical Industries: 19 th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules (CE Pharm 2017) Symposium Co-Chairs: Steffen

More information

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015)

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015) Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015) Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto

More information

Welcome to. January 27, Renaissance Mayflower Hotel Washington, DC USA

Welcome to. January 27, Renaissance Mayflower Hotel Washington, DC USA Welcome to January 27, 2014 Renaissance Mayflower Hotel Washington, DC USA What is CASSS? MISSION: What We Do CASSS is the global premier, non-profit scientific society facilitating the interaction among

More information

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2019)

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2019) Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2019) Symposium Co-chairs: Marta Germano, Janssen Infectious

More information

Welcome to the WCBP CMC Strategy Forum

Welcome to the WCBP CMC Strategy Forum Welcome to the WCBP CMC Strategy Forum We are pleased to welcome you to the 24 th WCBP CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product

More information

Northeast Regional Forum

Northeast Regional Forum Northeast Regional Forum Accelerated CMC Development Wyndham Boston Beacon Hill 5 Blossom Street Boston, MA 02114 Monday, October 8, 2018 Forum Co-chairs: Francis Poulin, Sanofi Bernice Yeung, Shire Pharmaceuticals

More information

ASMS Workshop Report

ASMS Workshop Report ASMS Workshop Report 1.Title of workshop and those presiding Title: Get Ready to Become an MS Rising Star -Young Mass Spectrometrists Workshop Presided by Olga Friese (Pfizer) and Dian Su (Genentech) 2.Date

More information

Welcome to the CMC Strategy Forum

Welcome to the CMC Strategy Forum Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The

More information

14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017)

14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017) 14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017) Symposium Co-chairs: Michael Boyne, BioTechLogic, Inc. Eef Dirksen, Synthon Biopharmaceuticals

More information

Biotherapeutics Interest Group Workshop 64th ASMS Conference and Allied Topics, June 5 - June 9, 2016, San Antonio, TX

Biotherapeutics Interest Group Workshop 64th ASMS Conference and Allied Topics, June 5 - June 9, 2016, San Antonio, TX Biotherapeutics Interest Group Workshop 64th ASMS Conference and Allied Topics, June 5 - June 9, 2016, San Antonio, TX Damian Houde, Ph.D. and Ashley Ruth, Ph.D. The Biotherapeutics Interest Group (formerly

More information

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast 2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges End-to-End Product Development Manufacturing, Supply, and Quality May 9-10, 2019 Hilton Long Beach Long Beach, CA As

More information

Welcome to CMC Strategy Forum Japan 2017

Welcome to CMC Strategy Forum Japan 2017 Welcome to CMC Strategy Forum Japan 2017 On behalf of the CASSS Board of Directors and the CMC Strategy Forum Global Steering Committee, we would like to extend to you a warm welcome to the second meeting

More information

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast 2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges End-to-End Product Development Manufacturing, Supply, and Quality May 9-10, 2019 Hilton Long Beach Long Beach, CA As

More information

Welcome to CMC Strategy Forum Japan 2015

Welcome to CMC Strategy Forum Japan 2015 Welcome to CMC Strategy Forum 2015 On behalf of the CASSS Board of Directors and the CMC Strategy Forum Global Steering Committee, we would like to extend to you a warm welcome to the second meeting of

More information

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast 2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges End-to-End Product Development Manufacturing, Supply, and Quality May 9-10, 2019 Hilton Long Beach Long Beach, CA As

More information

Table 1: CE-MS: Unexploited Opportunities in Process Development?

Table 1: CE-MS: Unexploited Opportunities in Process Development? Table 1: CE-MS: Unexploited Opportunities in Process Development? Session 1 Facilitator: Mei Han, Amgen Inc. Scribe: Yunan Wang, Amgen Inc. Session 2 Facilitator: Göran Hübner, Boehringer Ingelheim Pharma

More information

Welcome to the CMC Strategy Forum Europe 2015 Improving Biopharmaceutical Product Quality: Moving Implementation Forward

Welcome to the CMC Strategy Forum Europe 2015 Improving Biopharmaceutical Product Quality: Moving Implementation Forward Welcome to the CMC Strategy Forum Europe 2015 Improving Biopharmaceutical Product Quality: Moving Implementation Forward The ninth annual CMC Strategy Forum Europe, organized by CASSS - An International

More information

Welcome to the CMC Strategy Forum Europe 2010: Challenges Facing Biopharmaceutical Development in the Next Decade

Welcome to the CMC Strategy Forum Europe 2010: Challenges Facing Biopharmaceutical Development in the Next Decade Welcome to the CMC Strategy Forum Europe 2010: Challenges Facing Biopharmaceutical Development in the Next Decade The fourth annual CMC Strategy Forum Europe, organized by CASSS, An International Separation

More information

Sasidhar N. Nirudodhi, Lin Tzihsuan, Justin Sperry, Jason C. Rouse, James A. Carroll

Sasidhar N. Nirudodhi, Lin Tzihsuan, Justin Sperry, Jason C. Rouse, James A. Carroll Impact of Sequence Variants on the Higher-Order Structure (HOS) of Monoclonal Antibodies Using an Optimized HDX- MS Method with a Dual-Protease Co-Immobilized Column Format Sasidhar N. Nirudodhi, Lin Tzihsuan,

More information

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. Henry Luo, Regeneron Pharmaceuticals, Inc.

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. Henry Luo, Regeneron Pharmaceuticals, Inc. CE in the Biotechnology & Pharmaceutical Industries: 18 th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules (CE Pharm 2016) Symposium Co-Chairs: Steffen

More information

Creating a global community of industry, regulatory and academic professionals to solve scientific and technical problems in order to advance the

Creating a global community of industry, regulatory and academic professionals to solve scientific and technical problems in order to advance the Creating a global community of industry, regulatory and academic professionals to solve scientific and technical problems in order to advance the development of biopharmaceuticals. What is CASSS? CASSS

More information

Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009

Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009 Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009 Committee Leadership Dr. Ellen Evans (Schering-Plough Research Institute), Chair Dr. Tom Kawabata (Pfizer Inc.), Vice

More information

9th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2012)

9th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2012) 9th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2012) Symposium Co-Chairs: Yelena Lyubarskaya, Biogen Idec Inc. David Passmore, Bristol-Myers Squibb

More information

Intelligent Disulfide Bond Analysis

Intelligent Disulfide Bond Analysis Intelligent Disulfide Bond Analysis Why Study Disulfide Bonds? Save Money by making cell cultures more efficient! Regulations Process Control Higher Quality biotherapeutics Efficacy Protect from Competition

More information

Modern Approaches to Process Understanding

Modern Approaches to Process Understanding Biomanufacturing and Process Development (BPD) Modern Approaches to Process Understanding Thursday, September 18, 2014 1:00 pm - Registration begins 1:15 5:00 pm - Presentations & Networking North Carolina

More information

High Potent Medicines Conference

High Potent Medicines Conference 2nd Annual High Potent Medicines Conference Looking beyond scale-up, containment, regulatory aspects and safety of highly potent compounds Event Overview The HPAPI industry is expanding at a healthy rate

More information

Northern California Regional Forum

Northern California Regional Forum Northern California Regional Forum Cell and Gene Therapies South San Francisco Conference Center South San Francisco, CA Thursday, November 8, 2018 Co-chairs: Nomalie Jaya, Seattle Genetics, Inc. David

More information

High Potent Medicines Conference

High Potent Medicines Conference 2nd Annual 2nd Annual MARKETS MARKETSand andmarkets MARKETS High Potent Medicines Conference scale-up, containment, regulatory aspects and safety Main Looking Taunusbeyond Zentrum, Frankfurt, Germany of

More information

Welcome to the CMC Strategy Forum

Welcome to the CMC Strategy Forum Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The

More information

Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing

Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing We are pleased to welcome you to the CMC Strategy Forum. The

More information

Welcome to December Hotel Okura Tokyo, Japan

Welcome to December Hotel Okura Tokyo, Japan Welcome to 9 10 December 2013 Hotel Okura Tokyo, Japan What is CASSS? Non-profit professional membership society that provides networking and peer-to-peer learning opportunities for professionals involved

More information

FINAL PROGRAM. CASSS Bay Area Discussion Group. Co-chairs: Judy Chou, Medivation, Inc. Lance Wong, Strand Bio

FINAL PROGRAM. CASSS Bay Area Discussion Group. Co-chairs: Judy Chou, Medivation, Inc. Lance Wong, Strand Bio FINAL PROGRAM CASSS Bay Area Discussion Group Co-chairs: Judy Chou, Medivation, Inc. Lance Wong, Strand Bio South San Francisco Conference Center Thursday, October 13, 2016 1 Table of Contents Conference

More information

Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions

Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions Sponsored by the HESI Immunotoxicology Technical Committee Silver Spring, MD 22 October 2013 Objectives of the

More information

Calendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL

Calendar. The Clear Solution to Reach the Global Biopharma Audience.   INTERNATIONAL The Clear Solution to Reach the Global Biopharma Audience yvdavyd/getty Images & blackred/e+/getty Images 2017 EDITOrial Calendar Editorial Coverage Special Themed Issues January Biopharma Outlook for

More information

The room was more than 3/4 full with greater than 150 people in attendance.

The room was more than 3/4 full with greater than 150 people in attendance. Summary The room was more than 3/4 full with greater than 150 people in attendance. The questions were well distributed across all four panelists. All the Panelists were very interactive and were able

More information

Biochromatography Bring more Zen into your life and laboratory

Biochromatography Bring more Zen into your life and laboratory Seminar Biochromatography Bring more Zen into your life and laboratory Method development and maintaining peptide, protein, glycan and anti-body analyses by LC or LC-MS can be very time consuming and might

More information

Welcome to the CMC Strategy Forum

Welcome to the CMC Strategy Forum Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The

More information

Time Efficiencies to Be Gained from Platform Approaches to Drug Development

Time Efficiencies to Be Gained from Platform Approaches to Drug Development Time Efficiencies to Be Gained from Platform Approaches to Drug Development Monday, July 27th, 2015 Room 100 National Academy of Sciences Keck Center 500 5 th Street NW, Washington DC 20001 Meeting Description

More information

PRELIMINARY PROGRAM. Midwest Discussion Group. Co-chairs: James Carroll, Pfizer, Inc. Kathy Lee, Eli Lilly and Company

PRELIMINARY PROGRAM. Midwest Discussion Group. Co-chairs: James Carroll, Pfizer, Inc. Kathy Lee, Eli Lilly and Company PRELIMINARY PROGRAM Midwest Discussion Group Co-chairs: James Carroll, Pfizer, Inc. Kathy Lee, Eli Lilly and Company Eli Lilly and Company Campus June 2, 2016 1 Table of Contents Conference Program Partners..

More information

Streamlined and Complete LC-MS Workflow for MAM

Streamlined and Complete LC-MS Workflow for MAM Streamlined and Complete LC-MS Workflow for MAM Multiple Attribute Methodology (MAM) for Biotherapeutic Attribute Monitoring and Purity Testing BV MAM WORKFLOW Define Track Quantify Purity New Peaks Report

More information

Thermo Scientific Solutions for Intact-Protein Analysis. Better, Faster Decisions for. Biotherapeutic Development

Thermo Scientific Solutions for Intact-Protein Analysis. Better, Faster Decisions for. Biotherapeutic Development Thermo Scientific Solutions for Intact-Protein Analysis Better, Faster Decisions for Biotherapeutic Development Quickly and Accurately Assess Product Quality and Safety Therapeutic proteins and monoclonal

More information

Antibody Discovery at Evotec

Antibody Discovery at Evotec Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic

More information

PRELIMINARY AGENDA ** Attendees must already be registered to attend cphi Japan conference**

PRELIMINARY AGENDA ** Attendees must already be registered to attend cphi Japan conference** PRELIMINARY AGENDA ** Attendees must already be registered to attend cphi Japan conference** The Future of Biologics Development and Manufacturing 20 April 2017 13:00 16:00 Big Sight Exhibition Center,

More information

Protein Formulation Development Summit

Protein Formulation Development Summit Summit Register by August 10th and Save up to $200. See page 6 for details! Accelerating your protein therapeutic through analytical characterization, formulation development, delivery device selection

More information

Welcome to the CMC Strategy Forum Europe 2016

Welcome to the CMC Strategy Forum Europe 2016 Welcome to the CMC Strategy Forum Europe 2016 The 10 th annual CMC Strategy Forum Europe, organized by CASSS, will explore a number of critical topics focused on improving the quality in development and

More information

Tuesday, February 21, :15 a.m. 5:30 p.m. Registration Open. 8:15 a.m. 8:30 a.m. Continental Breakfast

Tuesday, February 21, :15 a.m. 5:30 p.m. Registration Open. 8:15 a.m. 8:30 a.m. Continental Breakfast 2017 PDA Pharmaceutical Quality Metrics and Quality Culture Conference February 21 22, 2017 Bethesda North Marriott Hotel & Conference Center Bethesda, MD As of January 30, 2017 Tuesday, February 21, 2017

More information

Vendor Neutral Host Cell Protein Analysis

Vendor Neutral Host Cell Protein Analysis Vendor Neutral Host Cell Protein Analysis Regulator Positions on HCPs VERY CLEAR Regulators classify residual host cell proteins (HCPs) as process-related impurities [ICH Q6B, Q2B]. Finding, measuring

More information

This is not unique to CE. It took for instance about 25 years for HPLC to establish itself properly in the pharmaceutical industry.

This is not unique to CE. It took for instance about 25 years for HPLC to establish itself properly in the pharmaceutical industry. CE Pharm 2017 Troubleshooting Report: CZE and CE-SDS the Discussion Continues Workshop facilitators: Tim Blanc 1, Cari Sänger-van de Griend 2 Scribes: Nathan Lacher 3, David Michels 4, Zoran Sosic 5 1

More information

CORPORATE SUPPORT CATALOG

CORPORATE SUPPORT CATALOG A m e r i c a Cough Conference n 7th American Cough Conference June 7-8, 2019 Reston, VA CORPORATE SUPPORT CATALOG Connecting You with the Who s Who of Cough 1 A m e r i c a n Cough Conference When you

More information

Reference Standards: Overview and Strategy for Development to Commercialization

Reference Standards: Overview and Strategy for Development to Commercialization Reference Standards: Overview and Strategy for Development to Commercialization John Ruesch Analytical Research and Development CASSS / WCBP CMC Strategy Forum: Reference Standards For Therapeutic Proteins

More information

Characterization of a fusion protein under native and denaturing conditions with maxis II

Characterization of a fusion protein under native and denaturing conditions with maxis II Characterization of a fusion protein under native and denaturing conditions with maxis II Abstract The maxis II UHR-QTOF was used to characterize key attributes of a fusion protein in its native conformation

More information

3rd Annual Global Drug Bioavailability Enhancement Summit

3rd Annual Global Drug Bioavailability Enhancement Summit 3rd Annual Global Drug Bioavailability Enhancement Summit Event Summary Most drugs on today s market display poor solubility, but the use of modern solubilization technologies can improve a drug product

More information

Purification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences

Purification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences Chromatography Purification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences Putting theory into practice In today s evolving workplace, it is vital to understand why

More information

INVESTOR PRESENTATION 2018

INVESTOR PRESENTATION 2018 INVESTOR PRESENTATION 2018 IMMUNOPRECISE ANTIBODIES, LTD. UNIT 3204-4464 MARKHAM STREET VICTORIA, BRITISH COLUMBIA V8Z 7X8, CANADA IMMUNOPRECISE.COM 1 Disclosures DISCLAIMER This presentation is not, and

More information

Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development

Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development We are pleased to welcome you to the CMC Strategy Forum. The purpose

More information

Seventh Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2010)

Seventh Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2010) Seventh Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2010) Symposium Co-Chairs: James Carroll, Pfizer, Inc. Jason Rouse, Pfizer, Inc. September

More information

TRIANNI Media Kit MEDIA CONTACT CORPORATE HEADQUARTERS. Trianni, Inc. San Francisco, CA

TRIANNI Media Kit MEDIA CONTACT CORPORATE HEADQUARTERS. Trianni, Inc. San Francisco, CA TRIANNI Media Kit CORPORATE HEADQUARTERS Trianni, Inc. San Francisco, CA Telephone: 1.866.374.9314 MEDIA CONTACT Mandy Boyd Director of Marketing @Trianni_mAb Website: Trianni.com TECHNOLOGY LEADERSHIP

More information

12:45 PM 1:45 PM Good, Bad, or Ugly? Understanding what the data is telling you Mike Murphy and Paul Belcher, GE Healthcare, Marlborough, MA, USA

12:45 PM 1:45 PM Good, Bad, or Ugly? Understanding what the data is telling you Mike Murphy and Paul Belcher, GE Healthcare, Marlborough, MA, USA GE Healthcare Agenda Sunday, June 17, 2018 10:00 AM 6:00 PM Registration Open 10:00 AM 4:00 PM Poster Drop-off 12:00 PM 12:45 PM Lunch Tutorial Session I 12:45 PM 1:45 PM Good, Bad, or Ugly? Understanding

More information

Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF

Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF Application Note Author David L. Wong Agilent Technologies, Inc. Santa Clara, CA, USA Introduction Monoclonal

More information

Comprehensive characterization of three IgG forms using CESI-MS

Comprehensive characterization of three IgG forms using CESI-MS Comprehensive characterization of three IgG forms using CESI-MS Bryan Fonslow 1, Olga V. Friese 2, and K. Steven Cook 2 1 SCIEX, Brea, CA and 2 Pfizer, Chesterfield, MO mabs, ADCs, biosimilars, and biobetters

More information

Industry Biomanufacturing Capacity Overview Patti Seymour Senior Consultant BioProcess Technology Consultants, Inc. DCAT March 14 17, 2016

Industry Biomanufacturing Capacity Overview Patti Seymour Senior Consultant BioProcess Technology Consultants, Inc. DCAT March 14 17, 2016 Global Biomanufacturing Trends, Capacity and Technology Drivers Industry Biomanufacturing Capacity Overview Patti Seymour Senior Consultant BioProcess Technology Consultants, Inc. DCAT March 14 17, 2016

More information

Repeatability of C100ht Biologics Analyzer, for High Throughput Glycan Screening

Repeatability of C100ht Biologics Analyzer, for High Throughput Glycan Screening Repeatability of C100ht Biologics Analyzer, for High Throughput Glycan Screening Marcia Santos, Tingting Li, Mervin Gutierrez, Anna Lou, and Clarence Lew SCIEX Separations, Brea, CA Introduction The ability

More information

SHORT COURSE. Practical Considerations for Biomarker Bioanalysis: Scientific and Regulatory Perspective SUNDAY, SEPTEMBER 17

SHORT COURSE. Practical Considerations for Biomarker Bioanalysis: Scientific and Regulatory Perspective SUNDAY, SEPTEMBER 17 SHORT COURSE SUNDAY, SEPTEMBER 17 OMNI PROVIDENCE HOTEL PROVIDENCE, RI Practical Considerations for Biomarker Bioanalysis: Scientific and Regulatory Perspective SPONSORED BY: Organized by: www.bostonsociety.org

More information

DRIVE DOWN COSTS. IMPROVE TIMELINES. NAVIGATE THE REGULATORY LANDSCAPE.

DRIVE DOWN COSTS. IMPROVE TIMELINES. NAVIGATE THE REGULATORY LANDSCAPE. 26-28 February 2019 Hilton Tokyo Bay Tokyo, Japan DRIVE DOWN COSTS. IMPROVE TIMELINES. NAVIGATE THE REGULATORY LANDSCAPE. BioProcess Experts Help You Accelerate Biologics Development and Production Jerry

More information

New Bio-Facilities Planned

New Bio-Facilities Planned New Bio-Facilities Planned Pfizer will construct a USD $350 MIL biosimilars manufacturing facility in Hangzhou, China; expected to serve domestic markets. The GE KuBio facility will use multiple 2,000

More information

Agilent s Annual Saturday Night ASMS Event Saturday, June 8, :00 pm 9:30 pm Minneapolis Convention Center

Agilent s Annual Saturday Night ASMS Event Saturday, June 8, :00 pm 9:30 pm Minneapolis Convention Center Agenda: Agilent s Annual Saturday Night ASMS Event Saturday, June 8, 2013 5:00 pm 9:30 pm Minneapolis Convention Center 5:00 pm 6:00 pm Reception Ballroom A&B 6:00 pm 7:00 pm Plenary Address Ion Mobility

More information

Industry View on the Relative Importance of Clonality of Biopharmaceutical-Producing Cell Lines

Industry View on the Relative Importance of Clonality of Biopharmaceutical-Producing Cell Lines Industry View on the Relative Importance of Clonality of Biopharmaceutical-Producing Cell Lines Christopher Frye, Eli Lilly & Company, Indianapolis IN Rohini Deshpande, Amgen Inc, Thousand Oaks CA Scott

More information

3rd Oral Drug Formulation Innovations June 26-27, 2019 Philadelphia, PA

3rd Oral Drug Formulation Innovations June 26-27, 2019 Philadelphia, PA 3rd Oral Drug Formulation Innovations June 26-27, 2019 Philadelphia, PA Uncovering the Future of Formulation Development, Oral Drug Delivery and Innovative Strategies to Accelerate Drug Product Time-To-Market

More information

AGENDA Scientist Mentoring & Diversity Program [SMDP Biotech]

AGENDA Scientist Mentoring & Diversity Program [SMDP Biotech] AGENDA 2014-2015 Scientist Mentoring & Diversity Program [SMDP Biotech] The International Center for Professional Development and its sponsors will host a training session for the 2014-2015 Scientist Mentoring

More information

Characterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry

Characterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry POSTER NOTE 65 Characterization of intact monoclonal antibody with microfluidic chip electrophoresis mass spectrometry Authors Chien-Hsun Chen, 1 Andreas Krupke, 2 Stephane Houel, 1 Aaron Bailey, 1 Aran

More information

rapiflex Innovation with Integrity Designed for Molecules that Matter. MALDI TOF/TOF

rapiflex Innovation with Integrity Designed for Molecules that Matter. MALDI TOF/TOF rapiflex Designed for Molecules that Matter. Innovation with Integrity MALDI TOF/TOF rapiflex TM The first MALDI-TOF/TOF that adapts to your needs. The rapiflex is the most advanced MALDI TOF/TOF system

More information

IMPORTANCE OF CELL CULTURE MEDIA TO THE BIOPHARMACEUTICAL INDUSTRY

IMPORTANCE OF CELL CULTURE MEDIA TO THE BIOPHARMACEUTICAL INDUSTRY IMPORTANCE OF CELL CULTURE MEDIA TO THE BIOPHARMACEUTICAL INDUSTRY Research, development and production of biopharmaceuticals is growing rapidly, thanks to the increase of novel therapeutics and biosimilar

More information

High-Throughput Glycan Screening to Remove Biopharmaceutical Development Bottlenecks

High-Throughput Glycan Screening to Remove Biopharmaceutical Development Bottlenecks High-Throughput Glycan Screening to Remove Biopharmaceutical Development Bottlenecks Mark Lies, Marcia Santos, and Tingting Li SCIEX Separations, Brea, CA Introduction Development of biopharmaceuticals

More information

An FDA Perspective on the Implementation of State-of-the-Art Analytical Methods for the Development of Therapeutic Proteins

An FDA Perspective on the Implementation of State-of-the-Art Analytical Methods for the Development of Therapeutic Proteins An FDA Perspective on the Implementation of State-of-the-Art Analytical Methods for the Development of Therapeutic Proteins Marjorie Shapiro, Ph.D. Office of Biotechnology Products/FDA WCBP 2018 Technical

More information

PAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS

PAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS PAVING THE WAY FOR ASSESSING IN VIVO DYNAMICS OF MULTIPLE QUALITY ATTRIBUTES FOR PROTEIN THERAPEUTICS CASSS Mass Spec September 21, 2017 Haihong Zhou Principal Scientist, Biologics, Vaccines & Bioanalytics

More information

GLOBAL MARKETS AND MANUFACTURING TECHNOLOGIES FOR PROTEIN DRUGS

GLOBAL MARKETS AND MANUFACTURING TECHNOLOGIES FOR PROTEIN DRUGS GLOBAL MARKETS AND MANUFACTURING TECHNOLOGIES FOR PROTEIN DRUGS BIO021E May 2016 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-288-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA

More information

3D Structure of Biologics in a Convenient Immunoassay Format

3D Structure of Biologics in a Convenient Immunoassay Format 3D Structure of Biologics in a Convenient Immunoassay Format Xing Wang, Ph.D. Array Bridge Inc. 5/25/2017 1 Topics Covered Today Why New Technologies? Technology Development. Case Studies for Novel and

More information

Agilent Technologies. Carl Myerholtz, Ph.D. Senior Director of QTOF Technology. FAPESP/Agilent Workshop August 30,

Agilent Technologies. Carl Myerholtz, Ph.D. Senior Director of QTOF Technology. FAPESP/Agilent Workshop August 30, Agilent Technologies Carl Myerholtz, Ph.D. Senior Director of QTOF Technology FAPESP/Agilent Workshop August 30, 2017 1 FAPESP/Agilent - Call for Research Proposals Focus Areas Biopharma Metabolomics In

More information

October 6th, 2017 De Doelen - ICC, Rotterdam, The Netherlands

October 6th, 2017 De Doelen - ICC, Rotterdam, The Netherlands October 6th, 2017 De Doelen - ICC, Rotterdam, The Netherlands The Gold Weigher, Salomon Koninck, 1654 Museum Boijmans van Beuningen, Rotterdam Conference Validation of biomarkers Bridging the innovation

More information

Innovation for Pharma to engage with the mobile user.

Innovation for Pharma to engage with the mobile user. www.healthnetworkcommunications.com/mobile Innovation for Pharma to engage with the mobile user 24-27 April 2012 Sheraton Hotel, Amsterdam, The Netherlands created by sponsor endorsed by Smart phones and

More information

8:00 am 8:15 am Opening Remarks Nanda Subbarao, Ph.D., Biologics Consulting Group, Inc. (Chair) Nina S. Cauchon, Ph.D., Amgen Inc.

8:00 am 8:15 am Opening Remarks Nanda Subbarao, Ph.D., Biologics Consulting Group, Inc. (Chair) Nina S. Cauchon, Ph.D., Amgen Inc. Co-Sponsored By: Tuesday, April 10, 2018 7:00 am 9:00 am Pre-Registration Badge Pick-Up Wednesday, April 11, 2018 7:00 am 9:00 am Registration Hours 7:00 am 8:00 am Continental Breakfast 8:00 am 8:15 am

More information

Edwin Moore, University of Illinois Lesley Redfern, AbbVie, Inc.

Edwin Moore, University of Illinois Lesley Redfern, AbbVie, Inc. SCIENTIFIC PROGRAM CASSS Midwest Discussion Group Co-chairs: Edwin Moore, University of Illinois Lesley Redfern, AbbVie, Inc. University Center of Lake County 1200 University Center Drive Grayslake, IL

More information

ANALYSIS OF AGGREGATES AND PARTICLES IN PROTEIN PHARMACEUTICALS

ANALYSIS OF AGGREGATES AND PARTICLES IN PROTEIN PHARMACEUTICALS ANALYSIS OF AGGREGATES AND PARTICLES IN PROTEIN PHARMACEUTICALS ANALYSIS OF AGGREGATES AND PARTICLES IN PROTEIN PHARMACEUTICALS Edited by Hanns-Christian Mahler F. Hoffmann-La Roche Ltd., Basel, Switzerland

More information

The Biopharma Symposium: Process and Formulations by GEA-NUS PPRL & Roquette University

The Biopharma Symposium: Process and Formulations by GEA-NUS PPRL & Roquette University The Biopharma Symposium: Process and Formulations by GEA-NUS PPRL & Roquette University Monday, 3 September 2018 Time Activity 08:00 08:30 Registration 08:30 09:00 Welcome address 09:00 09:50 Biopharmaceutical

More information

A Roadmap to Biomanufacturing

A Roadmap to Biomanufacturing MASSACHUSETTS INSTITUTE OF TECHNOLOGY A Roadmap to Biomanufacturing INTRODUCTION Join us in Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines and earn 3 CEUs and a MIT Professional

More information

Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars

Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars Jared Auclair, Ph.D. Northeastern University Department of Chemistry and Chemical Biology Barnett Institute of Chemical

More information

Welcome to the CMC Strategy Forum Europe 2017

Welcome to the CMC Strategy Forum Europe 2017 Welcome to the CMC Strategy Forum Europe 2017 The 11 th annual CMC Strategy Forum Europe, organized by CASSS, will explore a number of critical topics focused on improving the quality in development and

More information